Cargando…

Plasma bilirubin levels are reduced in first-episode psychosis patients and associates to working memory and duration of untreated psychosis

Schizophrenia is a severe mental disorder and one of its characteristics is cognitive impairments. Findings regarding levels of the heme metabolite and plasma antioxidant bilirubin in schizophrenia are inconclusive. However, a recently published study indicate that low levels of bilirubin may be imp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Becklén, Meneca, Orhan, Funda, Piehl, Fredrik, Cervenka, Simon, Sellgren, Carl M., Flyckt, Lena, Erhardt, Sophie, Fatouros-Bergman, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024299/ https://www.ncbi.nlm.nih.gov/pubmed/33824398 http://dx.doi.org/10.1038/s41598-021-87096-z

Ejemplares similares

CSF GABA is reduced in first-episode psychosis and associates to symptom severity
por: Orhan, F, et al.
Publicado: (2018)

No association between cortical dopamine D2 receptor availability and cognition in antipsychotic-naive first-episode psychosis
por: Lee, Maria, et al.
Publicado: (2021)

CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects
por: Xu, Chengai, et al.
Publicado: (2020)

Facial affect recognition in first-episode psychosis is impaired but not associated with psychotic symptoms()
por: Larsson, Cornelia, et al.
Publicado: (2022)

Identification of cerebrospinal fluid and serum metabolomic biomarkers in first episode psychosis patients
por: Shang, Pei, et al.
Publicado: (2022)

Screening for pathogenic neuronal autoantibodies in serum and CSF of patients with first-episode psychosis
por: Theorell, Jakob, et al.
Publicado: (2021)

Thalamic dopamine D2-receptor availability in schizophrenia: a study on antipsychotic-naive patients with first-episode psychosis and a meta-analysis
por: Plavén-Sigray, Pontus, et al.
Publicado: (2021)

T135. NEIGHBORHOOD-LEVEL PREDICTORS OF AGE AT ONSET AND DURATION OF UNTREATED PSYCHOSIS IN FIRST-EPISODE PSYCHOSIS
por: Ku, Benson, et al.
Publicado: (2018)

Clinical Predictors of Duration of Untreated Psychosis: Exploring Psychosocial and Clinical Predictors of Duration of Untreated Psychosis in First-Episode Psychotic Patients in Mzuzu, Malawi
por: Myaba, Japhet, et al.
Publicado: (2021)

F186. TAPETUM ABNORMALITIES IN FIRST-EPISODE PSYCHOSIS AND RELATIONSHIP TO SYMPTOM SEVERITY AND DURATION OF UNTREATED PSYCHOSIS
por: Lee, Sun Woo, et al.
Publicado: (2018)

Hippocampal glutamate and hippocampus subfield volumes in antipsychotic-naive first episode psychosis subjects and relationships to duration of untreated psychosis
por: Briend, Frédéric, et al.
Publicado: (2020)

White Matter Integrity, Duration of Untreated Psychosis, and Antipsychotic Treatment Response in Medication-Naïve First Episode Psychosis Patients
por: Kraguljac, Nina Vanessa, et al.
Publicado: (2020)

Association between duration of Untreated Psychosis and severer symptoms and poorer quality of life: study in First-Episode Psychosis patients
por: Pires, A. C. M., et al.
Publicado: (2023)

Impact of duration of untreated psychosis on the treatment outcome among first episode schizophrenia patients.
por: Fatima, Syeda Nissar, et al.
Publicado: (2022)

Association between referral source and duration of untreated psychosis in pathways to care among first episode psychosis patients in Northern Malawi
por: Kaminga, Atipatsa C., et al.
Publicado: (2019)

Effects of duration of untreated psychosis on long-term outcome of people hospitalized with first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2010)

O8.2. DURATION OF UNTREATED PSYCHOSIS (DUP) IS ASSOCIATED WITH WORSE RESPONSE TO TREATMENT IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOSIS
por: Cavalcante, Daniel, et al.
Publicado: (2018)

T154. WHITE MATTER INTEGRITY, DURATION OF UNTREATED PSYCHOSIS, AND ANTIPSYCHOTIC TREATMENT RESPONSE IN MEDICATION-NAïVE FIRST EPISODE PSYCHOSIS PATIENTS
por: Kraguljac, Nina, et al.
Publicado: (2020)

M169. HIPPOCAMPAL GLUTAMATE AND HIPPOCAMPUS SUBFIELD VOLUMES IN ANTIPSYCHOTIC-NAIVE FIRST EPISODE PSYCHOSIS SUBJECTS AND RELATIONSHIPS TO DURATION OF UNTREATED PSYCHOSIS
Publicado: (2020)

Examining evidence for neighbourhood variation in the duration of untreated psychosis
por: Kirkbride, J.B., et al.
Publicado: (2010)

Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia
por: Barnes, Thomas R. E., et al.
Publicado: (2008)

Duration of Untreated Psychosis in Chinese and Mauritian: Impact of Clinical Characteristics and Patients’ and Families’ Perspectives on Psychosis
por: Devi Thakoor, Jaya Prishni, et al.
Publicado: (2016)

Searching for psychosis: INTREPID (1): systems for detecting untreated and first-episode cases of psychosis in diverse settings
por: Morgan, Craig, et al.
Publicado: (2015)

Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan
por: Naqvi, Haider A., et al.
Publicado: (2009)

F256. CAN WE REDUCE THE DURATION OF UNTREATED PSYCHOSIS?
por: Oliver, Dominic, et al.
Publicado: (2018)

What are the physical and mental health implications of duration of untreated psychosis?
por: Salazar de Pablo, Gonzalo, et al.
Publicado: (2021)

Duration of untreated psychosis and clinical outcomes of first-episode schizophrenia: a 4-year follow-up study
por: QIN, Hongyun, et al.
Publicado: (2014)

The association between duration of untreated psychosis in first psychotic episode patients and help seeking behaviors in Jogjakarta, Indonesia
por: Marchira, Carla R., et al.
Publicado: (2016)

A cross-sectional mixed methods protocol to describe correlates and explanations for a long duration of untreated psychosis among patients with first episode psychosis in Uganda
por: Mwesiga, Emmanuel Kiiza, et al.
Publicado: (2019)

Duration of Untreated Psychosis in First-Episode Psychosis is not Associated With Common Genetic Variants for Major Psychiatric Conditions: Results From the Multi-Center EU-GEI Study
por: Ajnakina, Olesya, et al.
Publicado: (2021)

Short-term Clinical Outcome of Previously Untreated and Treated Schizophrenia and Impact of Duration of Untreated Psychosis
por: Bansal, Priyanka, et al.
Publicado: (2023)

Prognostic value of duration of untreated psychosis in long-term outcome of schizophrenia
por: Cechnicki, Andrzej, et al.
Publicado: (2011)

The Influence of Mental Health Literacy, Migration, and Education on the Duration of Untreated Psychosis
por: Takizawa, Naomi, et al.
Publicado: (2021)

The duration of untreated psychosis among U.S. Latinxs and social and clinical correlates
por: Santos, Maria M., et al.
Publicado: (2023)

Reducing the duration of untreated psychosis and its impact in the U.S.: the STEP-ED study
por: Srihari, Vinod H, et al.
Publicado: (2014)

S128. CORRELATION OF DURATION OF UNTREATED PSYCHOSIS WITH TREATMENT RESPONSE ON THE SYMPTOM DIMENSIONS OF SCHIZOPHRENIA
por: Elias, Beatriz Yukie, et al.
Publicado: (2018)

Geographical accessibility and duration of untreated psychosis: distance as a determinant of treatment delay
por: Kvig, Erling Inge, et al.
Publicado: (2017)

Substance use and duration of untreated psychosis in KwaZulu-Natal, South Africa
por: Davis, Glen P., et al.
Publicado: (2016)

Ethnic variations in duration of untreated psychosis: report from the CRIS-FEP study
por: Oduola, Sherifat, et al.
Publicado: (2020)

Duration Of Untreated Psychosis Among Patients With Schizophrenia – Change Over Time Study
por: Nivedita, .S, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8dlflssvhki8hu5l3bkkkdqt3b